Federal contract award
75A50124C00019
THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO IMPROVE THE SAFETY METRICS FOR EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO) THROUGH THE REDUCTION OF ANTICOAGULANT USAGE WITH THE RETENTION OF PERFORMANCE THROUGH THE USE OF A HIGHLY BIO-COMPATIBLE ECMO CIRC
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | BARDA - ASPR / DAAPPO / BARDA DCMA |
| NAICS | 541714 — Research and Development in Biotechnology (except Nanobiotechnology) |
| PSC | AN13 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $747.4K |
| Current contract value | $747.4K |
| Potential contract value / ceiling | $747.4K |
| Start date | May 22, 2024 |
| Current end date | Jun 21, 2026 |
| Potential end date | Jun 21, 2026 |
| Latest award activity | Aug 4, 2025 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 5 of 5 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Aug 4, 2025 | P00004 | $0 | THE PURPOSE OF THIS NO COST MODIFICATION IS TO UPDATE SECTION G.1 CONTRACTING OFFICER FROM REBECCA FOSTER TO AUDREY GLOVER. |
| Jun 16, 2025 | P00003 | $0 | THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO IMPROVE THE SAFETY METRICS FOR EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO) THROUGH THE REDUCTION OF ANTICOAGULANT USAGE WITH THE RETENTION OF PERFORMANCE THROUGH THE USE OF A HIGHLY BIO-COMPATIBLE ECMO CIRC |
| May 20, 2025 | P00002 | $0 | THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO IMPROVE THE SAFETY METRICS FOR EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO) THROUGH THE REDUCTION OF ANTICOAGULANT USAGE WITH THE RETENTION OF PERFORMANCE THROUGH THE USE OF A HIGHLY BIO-COMPATIBLE ECMO CIRC |
| Jul 22, 2024 | P00001 | $0 | THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO IMPROVE THE SAFETY METRICS FOR EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO) THROUGH THE REDUCTION OF ANTICOAGULANT USAGE WITH THE RETENTION OF PERFORMANCE THROUGH THE USE OF A HIGHLY BIO-COMPATIBLE ECMO CIRC |
| May 22, 2024 | 0 | $747.4K | THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO IMPROVE THE SAFETY METRICS FOR EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO) THROUGH THE REDUCTION OF ANTICOAGULANT USAGE WITH THE RETENTION OF PERFORMANCE THROUGH THE USE OF A HIGHLY BIO-COMPATIBLE ECMO CIRC |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.